# MADRIGAL PHARMACEUTICALS, INC. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v3 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1 | | Canonical entity | alpha:company:a2c6f396-355d-4322-a341-7ad70ce14f80 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/madrigal-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 21 | | Claims under review | 1 | | Evidence records | 4 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-09-12T21:30:58.287972+00:00 | | Last reviewed | 2026-09-12T21:30:58.287972+00:00 | ## Identity - Legal name: MADRIGAL PHARMACEUTICALS, INC. - Display name: MADRIGAL PHARMACEUTICALS, INC. ## Leadership - Bill Sibold: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:a2c6f396-355d-4322-a341-7ad70ce14f80:2. - Fred B. Craves, Ph.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:a2c6f396-355d-4322-a341-7ad70ce14f80:2. - Jacqualyn A. Fouse, Ph.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:a2c6f396-355d-4322-a341-7ad70ce14f80:2. - James M. Daly: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:a2c6f396-355d-4322-a341-7ad70ce14f80:2. - Julian C. Baker: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:a2c6f396-355d-4322-a341-7ad70ce14f80:2. - Kenneth M. Bate: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:a2c6f396-355d-4322-a341-7ad70ce14f80:2. - Paul A. Friedman, M.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:a2c6f396-355d-4322-a341-7ad70ce14f80:2. - Raymond Cheong, Ph.D., M.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:a2c6f396-355d-4322-a341-7ad70ce14f80:2. - Rebecca Taub, M.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:a2c6f396-355d-4322-a341-7ad70ce14f80:2. - Richard S. Levy, M.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:a2c6f396-355d-4322-a341-7ad70ce14f80:2. - Bill Sibold: President and Chief Executive Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:a2c6f396-355d-4322-a341-7ad70ce14f80:3. - Carole Huntsman: Executive Vice President and Chief Commercial Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:a2c6f396-355d-4322-a341-7ad70ce14f80:4. - David Soergel: Executive Vice President and Chief Medical Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:a2c6f396-355d-4322-a341-7ad70ce14f80:3. - David Soergel, M.D.: Executive Vice President and Chief Medical Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:a2c6f396-355d-4322-a341-7ad70ce14f80:4. - Mardi Dier: Executive Vice President and Chief Financial Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:a2c6f396-355d-4322-a341-7ad70ce14f80:3. - Shannon Kelley: Executive Vice President and Chief Legal Counsel. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:a2c6f396-355d-4322-a341-7ad70ce14f80:4. - Stephen D. Kelley: Executive Vice President and Chief Legal Counsel. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:a2c6f396-355d-4322-a341-7ad70ce14f80:3. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - MADRIGAL PHARMACEUTICALS, INC.. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:a2c6f396-355d-4322-a341-7ad70ce14f80:1. ## Headquarters - US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review. ## Entity Status - Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:a2c6f396-355d-4322-a341-7ad70ce14f80:1. ## Published Fact - US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:a2c6f396-355d-4322-a341-7ad70ce14f80:1. - Healthcare. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:a2c6f396-355d-4322-a341-7ad70ce14f80:1. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:evidence:company:a2c6f396-355d-4322-a341-7ad70ce14f80:1: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc). - alpha:evidence:company:a2c6f396-355d-4322-a341-7ad70ce14f80:2: [Madrigal Pharmaceuticals DEF 14A 2025-04-29](https://www.sec.gov/Archives/edgar/data/1157601/000110465925041254/tm2512589-3_def14a.htm). - alpha:evidence:company:a2c6f396-355d-4322-a341-7ad70ce14f80:3: MDGL executive roster source. - alpha:evidence:company:a2c6f396-355d-4322-a341-7ad70ce14f80:4: [MDGL DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1157601/000130817926000352/mdgl-20260428.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. - Current index memberships: Unavailable - Index membership events: Unavailable ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/madrigal-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/madrigal-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc) - [JSON-LD](https://registry.alpha.ac/api/public/companies/madrigal-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/madrigal-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp